Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: Kevin McCormack in your face

. Ever since Kevin McCormack, Director of Communications at the California Institute for Regenerative Medicine (CIRM), produced the first episode of “Stem Cells in Your Face,” I’ve been waiting for the sequel. If you, like me, are a fan, then the wait is over....

The waiting game: First human iPSC clinical trial on hold

. Nicole Forgione is a post-doctoral fellow working in the Fehlings group at the Toronto Western Research Institute. Currently she holds a Toronto Western Research Institute Fellowship to support her work on cell-based regenerative therapies for traumatic spinal cord...

Update from the Clinic: December

. Welcome to your Update from the Clinic for the month of December. bluebird bio’s first four patients are transfusion-free after treatment with its gene therapy Lentiglobin. Fate Therapeutics’ hematopoietic stem cell-modulating technology ProHema seems to be on track...

Right Turn: Bands and bandages

. If you’ve never heard of epidermolysis bullosa (EB), you’re not alone. This rare genetic disease, which occurs in one of 20,000 births, creates fragile skin that tears at the slightest touch and results in blisters, sores and scar tissue. There is no cure. EB...